128 related articles for article (PubMed ID: 8971536)
21. 5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules.
John WJ; Neefe JR; Macdonald JS; Cantrell J; Smith M
Cancer; 1993 Dec; 72(11):3191-5. PubMed ID: 8242541
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.
Ravandi F; Rytting ME; Osmon C; Braud EL; Roach RW; Edwards K; Winn R; Abbruzzese JL; Pazdur R
Anticancer Drugs; 1999 Jul; 10(6):519-24. PubMed ID: 10885898
[TBL] [Abstract][Full Text] [Related]
23. Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts.
Armstrong DK; Maw RD; Dinsmore WW; Blaakaer J; Correa MA; Falk L; Ferenczy AS; Fortier M; Frazer I; Law C; Moller BM; Oyakawa N
Genitourin Med; 1996 Apr; 72(2):103-7. PubMed ID: 8698355
[TBL] [Abstract][Full Text] [Related]
24. Current dermatologic therapy: use of interferons in genital warts.
Gross GE
J Am Acad Dermatol; 1993 Oct; 29(4):665. PubMed ID: 8292155
[No Abstract] [Full Text] [Related]
25. Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a.
Yee LK; Allegra CJ; Steinberg SM; Grem JL
J Natl Cancer Inst; 1992 Dec; 84(23):1820-5. PubMed ID: 1433371
[TBL] [Abstract][Full Text] [Related]
26. [Adjuvant systemic interferon alpha-2B treatment in treatment refractory anogenital Condylomata acuminata].
Erpenbach K; Derschum W; von Vietsch H
Urologe A; 1990 Jan; 29(1):43-5. PubMed ID: 2316080
[TBL] [Abstract][Full Text] [Related]
27. [Adjuvant 5-fluorouracil lacquer administration for reducing the rate of recurrence of condylomata acuminata following laser surgery treatment].
Erpenbach K; Derschum W; von Vietsch H; Reis M
Urologe A; 1989 May; 28(3):158-62. PubMed ID: 2741263
[TBL] [Abstract][Full Text] [Related]
28. Genital human papillomavirus infection in men. Diagnosis and treatment with a laser and 5-fluorouracil.
Bergman A; Nalick R
J Reprod Med; 1991 May; 36(5):363-6. PubMed ID: 2061884
[TBL] [Abstract][Full Text] [Related]
29. Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
Köhne CH; Wilke H; Hecker H; Schöffski P; Käufer C; Rauschecker H; Andreesen R; Ohl U; Lange HJ; Klaassen U
Ann Oncol; 1995 May; 6(5):461-6. PubMed ID: 7669711
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men.
Cardamakis E; Kotoulas IG; Relakis K; Metalinos K; Michopoulos J; Stathopoulos E; Mantouvalos H
Urology; 1995 May; 45(5):857-60. PubMed ID: 7747375
[TBL] [Abstract][Full Text] [Related]
31. Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
Oncology; 2000 Apr; 58(3):227-36. PubMed ID: 10765125
[TBL] [Abstract][Full Text] [Related]
32. A report of infusional 5-fluorouracil and subcutaneous alpha-2A-interferon in the treatment of advanced colorectal carcinoma.
Koo WH; Ang PT
Ann Acad Med Singap; 1996 Mar; 25(2):210-4. PubMed ID: 8799007
[TBL] [Abstract][Full Text] [Related]
33. [Condylomata acuminata and associated infections--possibilities for therapy with interferon].
Zwiorek L; Schmidt-Rhode P; Goerke K; Schulz KD
Zentralbl Gynakol; 1992; 114(8):409-13. PubMed ID: 1325717
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-alpha.
Kurokohchi K; Takaguchi K; Kita K; Masaki T; Kuriyama S
World J Gastroenterol; 2005 Sep; 11(34):5401-3. PubMed ID: 16149157
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic interaction of 5-fluorouracil and interferon alpha-2b with or without folinic acid.
b1p6uller J; Czejka M
Med Oncol; 1995 Mar; 12(1):47-53. PubMed ID: 8542247
[TBL] [Abstract][Full Text] [Related]
36. 5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study.
Palmeri S; Meli M; Danova M; Bernardo G; Leonardi V; Dastoli G; Rausa L; Russo A; Filippelli G; Palmieri G; Russo A; Della Vittoria Scarpati M; Lo Russo V; Di Lauro L; Colucci G; Bruni G; Piazzi M; Gebbia N; Spada S
J Cancer Res Clin Oncol; 1998; 124(3-4):191-8. PubMed ID: 9619746
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer.
Goey SH; Gratama JW; Primrose JN; Ward U; Mertelsmann RH; Osterwalder B; Verweij J; Stoter G
Br J Cancer; 1996 Dec; 74(12):2018-23. PubMed ID: 8980407
[TBL] [Abstract][Full Text] [Related]
38. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ
Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
[TBL] [Abstract][Full Text] [Related]
39. A case of condyloma acuminatum treated successfully with low-dose isotretinoin and interferon.
Yildirim M; Inaloz HS; Baysal V; Kesici D; Candir O
Int J Clin Pract; 2004 Sep; 58(9):889-91. PubMed ID: 15529524
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.
Wolmark N; Bryant J; Smith R; Grem J; Allegra C; Hyams D; Atkins J; Dimitrov N; Oishi R; Prager D; Fehrenbacher L; Romond E; Colangelo L; Fisher B
J Natl Cancer Inst; 1998 Dec; 90(23):1810-6. PubMed ID: 9839521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
